Volume 6 • Issue 8 • August 2012
ISSN 1814 3601
This issue of the Measles-Rubella Bulletin includes data on cases with rash onset in 2012 through July that were reported to the Regional Office in August. Detailed explanations of the indicators used in this Bulletin may be found in Measles Bulletin Vol. 1 Issue 13 (September 2007) and Measles Bulletin Vol. 2 Issue 4 (December 2008). These indicators are consistent with those recommended in the Weekly Epidemiological Record, No. 49, 2010, 85: 489–496.
Table 1A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2010—2012 2010 Country Australia Brunei Darussalam Cambodia China Hong Kong (China) Japan Lao People's Democratic Republic Macao (China) Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Completeness Timeliness 1 2 3
2011 Completeness 100% 100% 100% 100% 100% 100% 92% 100% 100% 100% 100% 75% 100% 100% 100% 75% 75% 95% 79% 89% Timeliness 100% 100% 92% 100% 100% 100% 92% 100% 92% 100% 83% 42% 92% 92% 92% 50% 67% 07 Feb 07 Feb 03 Feb 01 Mar 04 Feb 94% 82% 03 Mar 06 Mar 07 Mar 01 Mar 10 Mar 94% 88% Jan 10 Feb 02 Feb 08 Feb 10 Feb 15 Feb 06 Feb 07 Feb 15 Feb 07 Feb 10 Feb 08 Feb 07 Feb Feb 10 Mar 08 Mar 07 Mar 10 Mar 20 Mar 02 Mar 02 Mar 10 Mar 08 Mar 07 Mar 10 Mar 06 Mar Mar 10 Apr 04 Apr 04 Apr 10 Apr 10 Apr 05 Apr 10 Apr 18 Apr 02 Apr 06 Apr 09 Apr 04 Apr 17 Apr 31 Mar 09 Apr 09 Apr 10 Apr 03 Apr 100% 88% Apr 10 May 08 May 08 May 10 May 15 May 09 May 09 May 11 May 04 May 10 May 09 May 10 May 04 May 07 May 07 May 04 May 10 May 07 May 100% 94%
2012 May 10 Jun 05 Jun 09 Jun 10 Jun 11 Jun 04 Jun 10 Jun 10 Jun 07 Jun 08 Jun 08 Jun 08 Jun 12 Jun 10 Jun 07 Jun 06 Jun 10 Jun 04 Jun 100% 94%
1
Completeness 100% 100% 75% 100% 100% 100% 83% 100% 92% 100% 100% 67% 100% 92% 100% 92% 92% 94%
Timeliness 100% 100% 42% 58% 100% 100% 75% 100% 83% 92% 92% 33% 92% 92% 100% 25% 58%
Jun 10 Jul 09 Jul 09 Jul 10 Jul 15 Jul 10 Jul 05 Jul 09 Jul 05 Jul 11 Jul 09 Jul 09 Jul 13 Jul 06 Jul 10 Jul 07 Jul 10 Jul 03 Jul 100% 88%
Jul 10 Aug 03 Aug 04 Aug 10 Aug 14 Aug 10 Aug 07 Aug 10 Aug 07 Aug 10 Aug 09 Aug 03 Aug 10 Aug 04 Aug 02 Aug 08 Aug 10 Aug 01 Aug 100% 100%
Completeness 2 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 100% 71% 100% 100% 100% 100% 100% 98%
Timeliness 3 100% 100% 100% 86% 100% 100% 57% 100% 86% 100% 100% 29% 100% 100% 100% 86% 100% 91%
National measles surveillance monthly reports from January to July 2012. Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.
Legend: black = timely report; red = untimely report
Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and China may report to the Regional Office by the 15th (or the next working day) of the following month.
Table 1B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2010—2012 Country Australia Cambodia China Hong Kong (China) Japan Lao People's Democratic Republic Macao (China) Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam (northern) Viet Nam (southern) Fiji Completeness Timeliness 1 2 3
2010 Completeness 100% 42% 0% 100% 0% 58% 100% 92% 100% 100% 75% 100% 100% 100% 100% 83% 67% 77% 62% Timeliness 100% 25% 0% 100% 0% 58% 100% 58% 100% 33% 33% 83% 100% 100% 58% 50% 50% 100% 100% 0% 100% 100% 100% 100% 100% 100% 100% 83% 100% 100% 100% 100% 100% 92% 93%
2011 Completeness Timeliness 100% 100% 0% 100% 100% 100% 100% 100% 100% 92% 67% 100% 100% 100% 75% 100% 58% 88% 08 Feb 07 Feb 10 Feb 07 Feb 13 Feb 08 Feb 09 Feb 13 Feb 10 Feb 07 Feb 10 Feb 10 Feb 10 Feb 04 Feb 94% 82% 10 Mar 02 Mar 10 Mar 09 Mar 11 Mar 07 Mar 09 Mar 08 Mar 08 Mar 10 Mar 10 Mar 10 Mar 08 Mar 10 Mar 94% 88% 10 Apr 10 Apr 09 Apr 03 Apr 10 Apr 03 Apr 88% 88% 10 Apr 10 Apr 10 Apr 05 Apr 10 Apr 06 Apr 10 Apr Jan 09 Feb 06 Feb Feb 06 Mar 08 Mar Mar 03 Apr 08 Apr
2012 Apr
1
May 05 Jun 06 Jun 08 Jun 10 Jun 10 Jun 07 Jun 10 Jun 06 Jun 08 Jun 08 Jun 08 Jun 08 Jun 08 Jun 09 Jun 10 Jun 04 Jun 94% 94%
Jun 04 Jul 05 Jul 10 Jul 05 Jul 10 Jul 05 Jul 12 Jul 06 Jul 09-Jul 12 Jul 09 Jul 10 Jul 09 Jul 10 Jul 03 Jul 88% 76%
Jul 01 Aug 09 Aug 08 Aug 07 Aug 10 Aug 07 Aug 10 Aug 07 Aug 10 Aug 09 Aug 10 Aug 10 Aug 10 Aug 09 Aug 10 Aug 01 Aug 94% 94%
Completeness 100% 100% 0% 100% 100% 100% 100% 100% 100% 100% 86% 100% 100% 100% 100% 86% 100% 92%
2
Timeliness 3 100% 100% 0% 100% 100% 100% 100% 71% 100% 100% 57% 100% 100% 100% 100% 86% 100% 88%
02 May 10 May 10 May 09 May 10 May 04 May 09 May 08 May 10 May 10 May 09 May 10 May 10 May 04 May 10 May 07 May 94% 94%
National measles laboratory monthly reports from January to July 2012. Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year. National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.
Table 2A. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2011—2012 1 2011 Country
2012 1 Discarded cases 0 6 2889 24 692 219 399 326 15 3341 183 0 44 2954 131 0 14 208 0 0 538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 49 945
Population (in Suspected 3 millions) 2 measles cases No data
Confirmed measles cases Lab 166 4 320 8951 6 322 12 1 1445 0 428 0 3240 40 143 22 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15 102
Epi-linked 26 0 0 13 1 9 17 0 82 0 105 0 171 0 No data
Clinical No data
Total 192 4 722 9943 12 410 113 1 1569 0 599 0 6555 43 143 745 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 21 053
Measles Pending Deaths due to incidence per classification measles 1 million pop. 0 0 0 7 0 0 0 0 0 0 3 6 3 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 0 0 1 10 0 0 0 0 4 0 0 0 28 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 47 8.5 9.9 50.5 7.4 1.7 3.2 18.0 1.8 54.4 0 135.7 0 69.1 0.9 27.6 8.4 0 0 2.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6 Green Yellow Red
Population (in 2 millions) 22.92 0.41 14.48 1353.60 7.20 126.43 6.37 0.57 29.32 2.84 4.46 7.17 96.47 48.59 5.26 89.73 0.07 0.02 0.88 0.28 0.18 0.10 0.06 0.11 0.01 0.26 0.00 0.06 0.02 0.18 0.57 0.00 0.10 0.01 0.25 0.01 1819.01
Suspected 3 measles cases No data
Confirmed measles cases Discarded cases Lab 50 1 1 3358 3 136 1 1 1197 0 45 0 499 1 23 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5318
Epi-linked 7 0 0 2 0 2 0 0 63 0 3 0 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 92
Clinical No data
Total 57 1 1 3439 6 165 6 1 1 455 0 48 0 946 1 24 207 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6357 No data
Pending Deaths due to classification measles 0 0 3 251 0 0 7 0 905 0 9 3 185 1 1 36 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1402 0 0 0 6 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10
Annualized Measles incidence per 1 million pop. 4.3 4 0 4.4 1.4 2.2 1.6 3.0 85.1 0 18.4 0 16.8 0 7.8 4.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6.0
Australia 22.61 Brunei Darussalam 0.41 Cambodia 14.31 China 1347.57 Hong Kong (China) 7.12 Japan 126.50 Lao People's Democratic Republic 6.29 Macao (China) 0.56 Malaysia 28.86 Mongolia 2.80 New Zealand 4.41 Papua New Guinea 7.01 Philippines 94.85 Republic of Korea 48.39 Singapore 5.19 Viet Nam 88.79 Pacific island countries and areas American Samoa Cook Islands Fiji 4 French Polynesia Guam Kiribati Marshall Islands Micronesia, Federated States of Nauru New Caledonia Niue Northern Mariana Islands Palau Samoa Solomon Islands Tokelau Tonga Tuvalu Vanuatu Wallis and Futuna Western Pacific Region 1 2 3 4
10 3611 34 642 231 809 439 16 4910 183 No data
50 9512 174 No data
0 402 979 5 79 84 0 42 0 66 0 3144 3 No data
14 954 0 0 538 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 70 079
81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 505
642 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5446
5 725 24 644 104 306 369 13 5243 511 70 3 2329 67 37 767 0 0 129 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 35 322
0 0 79 3 27 5 0 195 0 0 0 432 0 1 205 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 947
4 721 20 954 98 141 356 12 2883 511 13 0 1198 65 12 524 0 0 128 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 27 620
0.07 0.02 0.87 0.27 0.18 0.10 0.05 0.11 0.01 0.25 0.00 0.06 0.02 0.18 0.55 0.00 0.10 0.01 0.25 0.01 1808.80
National measles surveillance monthly reports from January to July 2012. Population figures from United Nations World Population Prospects: The 2010 Revision. Australia reports only confirmed cases. Classification is provisional based on laboratory data only.
<1 confirmed measles case / 1 000 000 population 1–9.9 confirmed measles case / 1 000 000 population >= 10 confirmed cases / 1 000 000 population
2
Table 2B. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2011—2012 1 1 2011 2012 Country Discarded measles rate per 100 000 pop ≥2 Australia 4 Insufficient data Brunei Darussalam 1.5 Cambodia 20.2 China 1.8 Hong Kong (China) 3.1 Japan 0.3 Lao People's Democratic Republic 5.2 Macao (China) 2.7 Malaysia 11.6 Mongolia 6.5 Insufficient data New Zealand 4 Papua New Guinea 0.6 Philippines 3.1 Republic of Korea 0.3 Singapore 4 Insufficient data Viet Nam 16.0 Pacific island countries and areas American Samoa 0 Cook Islands 0 Fiji 62.0 French Polynesia 0 Guam 0 Kiribati 0 Marshall Islands 0 Micronesia, Federated States of 0 Nauru 0 New Caledonia 0 Niue 0 Northern Mariana Islands 0 Palau 0 Samoa 0 Solomon Islands 0 Tokelau 0 Tonga 0 Tuvalu 0 Vanuatu 0 Wallis and Futuna 0 Western Pacific Region 2.8 Second level units with ≥ 1 discarded cases per 100 000 pop ≥ 80% Insufficient data
Suspected cases with adequate investigation ≥ 80% Insufficient data
Suspected cases with adequate blood specimens ≥ 80% Insufficient data 2
Percent clinically confirmed cases 3
Annualized discarded measles rate per 100 000 pop ≥2 Insufficient data
Second level units with ≥ 1 discarded cases per 100 000 pop (annualized) ≥ 80% Insufficient data
Suspected cases with adequate investigation ≥ 80% Insufficient data
Suspected cases with adequate blood specimens ≥ 80% Insufficient data 2
Percent clinically confirmed cases 3
≤ 10% Insufficient data
≤ 10% Insufficient data
100.0% 75.0% 71.0% 100.0% 4.3% 70.6% 100.0% 93.8% 36.4% Insufficient data
60.0% 28.5% 97.2% 98.2% Insufficient data
90.0% 91.8% 90.6% 99.1% Insufficient data
29.3% 100.0% 46.2% 59.6% Insufficient data
53.8% 100.0% 84.5% 100.0% Insufficient data
20.0% 88.2% 0% Insufficient data
40.0% 88.6% 64.3% Insufficient data
82.0% 98.0% 87.1% Insufficient data
0% 55.7% 9.8% 41.7% 19.3% 74.3% 0% 2.7% 0% 11.0% 0% 48.0% 7.0% Insufficient data
1.7 8.5 2.7 2.3 0.2 9.6 3.6 16.9 30.8 Insufficient data
100.0% 54.2% 74.2% 100.0% 0% 64.7% 100.0% 93.8% 40.9% Insufficient data
60.0% 53.5% 98.9% 88.1% Insufficient data
80.0% 97.5% 95.1% 99.0% Insufficient data
47.8% 100.0% 66.4% 67.1% Insufficient data
77.7% 100.0% 70.7% 99.8% Insufficient data
0 2.1 0.2 Insufficient data
0% 52.9% 6.3% Insufficient data
100.0% 71.9% 83.6% Insufficient data
100.0% 91.2% 92.5% Insufficient data
0% 0% 2.3% 50.0% 16.4% 83.3% 0% 13.4% 0% 0% 0% 45.7% 0% Insufficient data
84.4% 0% 0% 100% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 52.3%
20.0% Not applicable Not applicable
33.3% Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable
86.2% Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable
1.0 0 0 25.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.7
28.1% 0% 0% Insufficient data
57.1% Not applicable Not applicable
66.2% Not applicable Not applicable Insufficient data Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable
99.0% Not applicable Not applicable
0.0% Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable
0% Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable
0% Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable Not applicable
1 2
70.4% Green Yellow Red
77.8%
26.3%
0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 34.0%
89.5%
90.7%
15.1%
National measles surveillance monthly reports from January to July 2012. Excludes epidemiologically-linked and clinically confirmed cases. Among all confirmed cases. Reports only confirmed cases.
3 4
Reached or surpassed target Nearly reached target: 1.00–1.99 for non-measles suspected case rate; 10.1–25% for percent clinically confirmed cases; 60–79% for other indicators Substantially below target
3
Table 3A. Measles and rubella laboratory performance, WHO Western Pacific Region, 20111 Measles Measles and rubella Serum Country Total number of cases tested Total number of samples received Samples tested for measles IgM Measles IgM (+) Measles IgM equiv Measles IgM (-) Measles IgM pending Serology Blood Results ≤ 7 days Virus detection Measles Virus isolation/detection (swab, urine and others) No. of samples tested 0 0 Measles Reverse TranscriptionPolymerase Chain Reaction No. of samples tested 167 0 Rubella Serum and blood (includes DBS) Samples Total number tested for of lab rubella IgM confirmed cases No. Rubella IgM (+) Rubella IgM pending
DBS samples
Rubella IgM equiv
No.
No.
No.
No.
%
No.
No. received 0 170
No. (+) 8
%
No. of isolates 0 0
No. of (+)
No.
No.
No.
Australia Cambodia China Hong Kong (China) Japan Lao People's Democratic Republic Macao (China) Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam (northern) Viet Nam (southern) Fiji Total 1
159 3201
254 3208
77 3038
25 288
6 2
46 2748
59.7 90.5
0 0
100 55.6
134 0
111 296
40 3038
5 1048
1 60
0 0
379
434
342
6
5
331
96.8
0
0
-
98.2
19
2
29
6
7
352
45
2
0
181 47 4923 182 1175 144 7620 243 581 2466 1729 527 23 557
181 47 5009 182 1424 144 7620 288 831 2466 1739 528 24 355
181 47 4975 182 693 60 7620 227 239 1460 1475 518 21 134
12 1 1582 0 161 0 3829 41 56 8 6 2 6017
0 0 109 0 11 0 424 21 2 4 9 1 594
169 46 3284 182 520 60 3367 165 181 1447 1460 515 14 521
93.4 97.9 66.0 100 75.0 100 44.2 72.7 75.7 99.1 99.0 99.4 68.7
0 0 0 0 1 0 0 0 0 1 0 0 2
0 0 0 0 2 84 0 0 0 0 0 10 266
0 0 0 8
82.1 97.9 100 100 99.0 30.7 72.6 98.2 97.6 62.4 92.9 47.2 78.6
0 0 4145 0 17 0 179 17 273 55 10 0 4715
0 0 118 0 2 0 30 1 42 0 0 0 195
0 0 481 0 701 0 0 79 65 0 10 0 1532
0 0 114 0 389 0 0 13 4 0 0 0 660
12 1 1582 0 467 0 3829 42 95 8 6 2 6458
181 47 3360 182 95 144 3831 227 376 2465 1721 527 16 586
37 1 383 14 4 8 1115 19 9 1413 1084 151 5336
21 1 193 5 1 9 322 32 18 134 110 57 966
0 0 1 1 12 2 0 0 0 0 0 0 16
National measles laboratory monthly reports from January to December 2011.
4
Table 3B. Measles and rubella laboratory performance, WHO Western Pacific Region, 20121 Measles Measles and rubella Serum Country Total number of cases tested Total number of samples received Samples tested for measles IgM Measles IgM (+) Measles IgM equiv Measles IgM (-) Measles IgM pending Serology Blood Results ≤ 7 days Virus detection Measles Virus isolation/detection (swab, urine and others) No. of samples tested 0 68 Measles Reverse TranscriptionPolymerase Chain Reaction No. of samples tested 28 68 Rubella Serum and blood (includes DBS) Samples Total number tested for of lab rubella IgM confirmed cases No. Rubella IgM (+) Rubella IgM pending
DBS samples
Rubella IgM equiv
No.
No.
No.
No.
%
No.
No. received 0 77
No. (+) 0
%
No. of isolates 0 0
No. of (+)
No.
No.
No.
Australia Cambodia China Hong Kong (China) Japan Lao People's Democratic Republic Macao (China) Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam (northern) Viet Nam (southern) Fiji Total 1
33 723
44 725
13 645
8 0
1 1
4 644
30.8 100
0 0
100 99.1
25 0
24 0
11 645
4 168
0 0
0 0
239
269
242
3
3
236
97.5
0
0
-
98.2
13
2
17
5
3
231
16
3
0
296 32 5557 512 228 7 1992 156 407 287 181 129 10 779
296 32 6345 514 249 7 2001 162 531 287 192 129 11 783
296 32 5232 512 104 7 1967 158 181 209 179 127 9904
1 2 1485 0 8 0 540 12 11 1 1 0 2072
4 0 91 0 2 0 100 9 4 4 0 0 219
291 30 3656 512 94 7 1323 137 166 204 178 127 7609
98.3 93.8 69.9 100 90.4 100 67.3 86.7 91.7 97.6 99 100 76.8
0 0 0 0 0 0 4 0 0 0 0 0 4
0 0 0 0 0 0 0 0 0 0 0 2 79
0 0
84.7 100 98.9 100 99 73 98.0 100 97.1 88.5 100 92.2 98.1
0 0 800 2 4 0 26 1 116 0 13 0 1043
0 0 78 0 0 0 1 0 4 0 0 0 85
0 0 0 2 129 0 3 21 4 0 13 0 285
0 0 0 0 43 0 0 0 4 0 0 0 77
1 2 1519 0 48 0 541 12 13 1 1 0 2165
296 32 3676 512 31 7 1427 156 236 287 179 129 7855
47 3 462 225 3 1 103 7 12 88 23 24 1186
57 0 175 10 1 0 97 14 9 26 13 8 413
0 0 0 0 0 0 5 0 0 0 0 0 5
National measles laboratory monthly reports from January to July 2012.
5
Table 4A. Measles genotype distribution of cases with onset in 2011 and 20121, WHO Western Pacific Region 2011 Country Total confirmed cases 1 192 4 722 9943 12 410 113 1 1569 0 599 0 6555 43 143 745 2 21 053
2012 2
GENOTYPES Total Lab confirmed 1 B3 -
Pending D4 31 51 22 1 105
Total
D8 25 1 7 1 10 3 9 56
D9 38 19 3 35 33 12 24 12 33 209
D11 1 1
G3 1 3 1 5
H1 1 6 175 1 12 2 197
A 5 2 4 3 1 15 3 2 5 103 0 25 178 5 98 12 1 49 0 37 0 24 13 46 2 0 593
Total confirmed cases 1 57 1 1 3439 6 165 6 1 1,455 0 48 0 946 1 24 207 0 6357
GENOTYPES 2 Total Lab confirmed 1 Pending B3 2 2
Total
D4 5 7 12
D8 10 37 20 1 68
D9 2 6 2 8 50 5 4 77
D11 0
G3 1 1
H1 67 1 5 73
A 1 1 2 1 5 0 16 0 0 74 3 57 0 0 70 0 9 0 5 0 4 0 0 238
Australia Brunei Darussalam Cambodia China Hong Kong (China) Japan Lao People's Democratic Republic Macao (China) Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam Pacific island countries and areas Total 1 2
166 4 320 8951 6 322 12 1 1445 0 428 0 3240 40 143 22 2 15 102
50 1 1 3358 3 136 1 1 1,197 0 45 0 499 1 23 2 0 5318
Sources: National measles surveillance monthly reports from January to July 2012 (Table 2A). Sources: National and regional measles reference laboratory monthly reports from January to July 2012 and the Measles Nucleotide Sequence online database (MeaNS), whichever has the greater number.
6
Table 4B. Rubella genotypes distribution of cases with onset in 2011 and 20121, WHO Western Pacific Region 2011 Country Samples tested for rubella IgM 1 40
2012 2
Rubella IgM positive 1 5
Genotypes 1E -
Total 1j 1 -
2B 18 8 2 2 6 5 2 15 2 0 0 0 172 15 5 3 0 6 0 5 2 0 0 0 15 2
Samples tested for rubella IgM 1 11
Rubella IgM positive 1 4
Genotypes 2 Pending 1E -
Total
1j 2 -
2B 3 52 8 1 2 1 0 0 3 156 14 1 0 0 2 0 0 0 3 0 0 0 0
Australia Brunei Darussalam Cambodia China Hong Kong (China) Japan Lao People's Democratic Republic Macao (China) Malaysia Mongolia New Zealand Papua New Guinea Philippines Republic of Korea Singapore Viet Nam
3038
1048
154
645
168
104
352
45
7 2
231
16
6 -
181 47 3360 182 95 144 3831 227 376 4186 527
37 1 383 14 4 8 1115 19 9 2497 151
1 -
296 32 3676 512 31 7 1427 156 236 466 129
47 3 462 225 3 0 103 7 12 111 24
-
Pacific island countries and areas Total 1 2
16 586
5336
164
1
60
225
7855
1185
110
2
67
0
179
Sources: National measles laboratory monthly reports from January to July 2012 (Table 3). Sources: National and regional measles reference laboratory monthly reports from January to July 2012 and the Measles Nucleotide Sequence online database (MeaNS), whichever has the greater number.
Expanded Programme on Immunization Regional Office for the Western Pacific World Health Organization P.O. Box 2932, 1000 Manila, Philippines Tel. No. (63 2) 5288001 Fax No. (63 2) 5211036, 5260279 Please send your comments and monthly data before the 10th of the month to: WPR_EPIdata@wpro.who.int
7